Depending on tumor stage, the PTX-3 gene is methylated differently through two enhancers: enhancer-1 is silenced in initial colorectal cancer stages, while enhancer-2 is stimulated during carcinoma progression [79,98]. This evidence concerns the gene PTX3 and colorectal cancer.